New immune mechanism helps explain why ovarian cancer stops responding to chemotherapy

Scientists at The Wistar Institute have identified a new mechanism behind the chemotherapy resistance that makes ovarian cancer so lethal.

In a new study published in The Journal for ImmunoTherapy of Cancer, the researchers show that chemotherapy triggers an inflammatory cascade that recruits immune cells into the tumor microenvironment, which ultimately function to protect the cancer from subsequent chemotherapy. ...